Fig. 4.
The effect of GM-CSF rescue from apoptosis on ceramide levels in TF-1 cells. TF-1 cells were treated with γ radiation (5 Gy) in either the presence or absence of GM-CSF (100 U/mL) in complete RPMI supplemented with 20% FBS, and harvested at 2, 4, 8, 10, and 60 minutes postirradiation. Extraction and measurement of ceramide was performed as described37 by assay of 32P incorporated upon phosphorylation of ceramide to ceramide 1-P by DAG kinase. Ceramide 1-P was resolved by TLC using CHCl3:CH3OH:acetic acid (65:15:5, vol/vol) as solvent, detected by autoradiography and the incorporated32P was quantified by phosphoimaging (Fugi BAS1000, Fugi Medical Systems). The level of ceramide was determined by comparison to a concomitantly run standard composed of known amounts of ceramide. Ratios were derived by comparison to ceramide levels of unirradiated TF-1 cells grown in either the presence or absence of GM-CSF. The values were derived from duplicate experiments and error bars represent standard deviations into which mean values were incorporated.